ST
Insider buying
Scott Thomas Smith bought $56K of Ascendis Pharma A/S (ASND) stock
Scott Thomas Smith, EVP & Chief Financial Officer of Ascendis Pharma A/S (ASND), bought 250 shares of ASND stock worth $56K, per an SEC Form 4 filed Jun 1, 2026.
It was an open-market purchase.
The trade happened on May 29, 2026, 3 days before it was made public.
ASND has moved +6.0% since the trade date, from $224.11 to $237.59 (Sep 21, 2026 close).
- Traded
- May 29, 2026
- Disclosed
- Jun 1, 2026
- Filing delay
- 3 days
- Price since
- +6.0%
- Role
- EVP & Chief Financial Officer
- Source
- SEC Form 4
More ASND insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.